Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Danziger-Isakov, Lara  [Clear All Filters]
2024
Fisher BT, Blumenstock J, Boge CLK, Shuster S, Seif AE, Green M, Michaels MG, Alexander JL, Ardura MI, Miller TP, et al. Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies. Pediatr Transplant. 2024;28(3):e14750.
2023
Schuster JE, Hamdan L, Dulek DE, Kitko CL, Batarseh E, Haddadin Z, Stewart LS, Stahl A, Potter M, Rahman H, et al. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2023.
Morales MK, Danziger-Isakov L, Nematollahi S. A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum. Curr Opin Organ Transplant. 2023.
2018
Danziger-Isakov L, Englund J, Green M, Posfay-Barbe KM, Zerr DM. Cytomegalovirus in Pediatric Hematopoietic Stem Cell Transplantation: A Case-Based Panel Discussion of Current Challenges. J Pediatric Infect Dis Soc. 2018;7(suppl_2):S72-S74.
Danziger-Isakov L, Englund J, Green M, Posfay-Barbe KM, Zerr DM. Cytomegalovirus in Pediatric Hematopoietic Stem Cell Transplantation: A Case-Based Panel Discussion of Current Challenges. J Pediatric Infect Dis Soc. 2018;7(suppl_2):S72-S74.
2016
Teusink-Cross A, Davies SM, Danziger-Isakov L, El-Bietar J, Grimley MS. Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant. 2016.
Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A, Wallace G, Teusink-Cross A, Davies SM. Terminal complement blockade after HSCT is safe without meningococcal vaccination. Biol Blood Marrow Transplant. 2016.